Company intelligence / Profile preview

GI Windows

Westwood, Massachusetts, United Statesgiwindows.com ↗

Ownership: Private
Development stage: Preclinical

Overview

GI Windows has developed a novel, less invasive magnetic compression anastomosis device platform ("Flexagon") that enables sutureless and stapler-free creation of gastrointestinal connections. The technology has demonstrated safety and feasibility in preclinical models, received FDA Breakthrough Device Designation, and recently obtained FDA 510(k) clearance for its Flexagon system. Clinical trials are ongoing to support broader commercialization

Therapeutic areas: GastroenterologyMetabolic Disorders
Modalities: Device (specifically, self-forming magnetic anastomosis system)
Industry: Surgical Medical Devices

Partnerships

Orlando Health VenturesRex Health VenturesJohnson & Johnson Innovation–JJDCJCInvestcoSonder Capital

Beyond the preview

Go deeper on GI Windows.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GI Windows.

Explore the full profile